Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

首先，在新辅助治疗中，传统观点认为总体病理完全缓解（tpCR）与预后密切相关。然而，我们在临床实践中观察到，部分患者的乳腺达到pCR（bpCR），但腋窝淋巴结未达到pCR；也有一些患者乳腺未达到pCR，但腋窝淋巴结达到pCR。这种现象相对少见，因此我 ...

Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the ...

Antibody-Drug Conjugate Found Effective Against ... hemispheric glioma and discovered an unexpected vulnerability to CDK4/6 ... New Study Uncovers Key Mechanisms Responsible for the Transformation ...

The antibody drug conjugate was approved for patients with unresectable or metastatic ... No significant survival benefits were found when comparing three CDK4/6 inhibitor combinations during initial ...

The global breast cancer therapeutics market is expected to grow from US$ 31.07 billion in 2022 to US$ 63.9 billion by 2030, ...

Fresh from the $43 billion acquisition of antibody-drug conjugate (ADC ... Among the new phase 3 starts are CDK4 inhibitor atirmociclib as a second-line therapy for hormone receptor-positive ...

After hours: March 20 at 5:29:37 PM EDT Loading Chart for ONC ...

A comprehensive literature review was conducted for all medications on the formulary of Bedlam Clinic, a free evening clinic for the medically indigent or working poor, offered by the University ...